North America Electronic Clinical Outcome Assessment (eCOA) Market - Industry Trends and Forecast to 2035
Market Report I 2023-12-01 I 151 Pages I Data Bridge Market Research
The North America electronic Clinical Outcome Assessment (eCOA) market is expected to reach USD 2,048,224.01 thousand by 2031 from USD 616,857.64 thousand in 2023, growing at a CAGR of 16.2% during the forecast period of 2024 to 2031.
Market Segmentation
North America Electronic Clinical Outcome Assessment (eCOA) Market, By Type (Clinician Reported Outcome Assessment (CLINRO), Patient Reported Outcome Assessment (PRO), Observer Reported Outcome Assessment (OBSRO), and Performance Outcome Assessment (PERFO)), Modality (Site-Based Solutions, Web Solutions, and Handheld), End User (Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Firms, Medical Device Companies, Hospitals/Healthcare Providers, Consulting Service Companies, Academic & Research Institutes, and Others), Delivery Mode (Cloud-Based and Web-Hosted), Country (U.S., Canada, and Mexico) - Industry Trends and Forecast to 2031
Overview of North America Electronic Clinical Outcome Assessment (eCOA) Market Dynamics
Driver
- Growing acceptance of eCOA among clinical research professionals
Restraint
- Implementation of 'Bring Your Own Device' (BYOD) technology in clinical trials
Opportunity
- Growing adoption of cloud-based services
Market Players
Some of the major market players operating in the North America electronic Clinical Outcome Assessment (eCOA) market are:
- Medidata (A Subsidiary of Dassault Systemes)
- Clario
- IQVIA Inc
- Signant Health
- ArisGlobal
- TransPerfect Life Sciences
- WCG Clinical.
- Kayentis
- Castor
- Suvoda LLC
- Vitalograph
- Medable Inc.
- Cloudbyz
- YPrime LLC.
- Merative
- EvidentIQ
- Climedo Health GmbH
- RAYLYTIC GmbH
- Clinical Ink
- Assistek
- Pattern Health Technologies, Inc.
- clincapture
- Crucial Data Solutions
TABLE OF CONTENTS
1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 OVERVIEW OF THE NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET 16
1.4 LIMITATIONS 17
1.5 MARKETS COVERED 18
2 MARKET SEGMENTATION 20
2.1 MARKETS COVERED 20
2.2 GEOGRAPHICAL SCOPE 21
2.3 YEARS CONSIDERED FOR THE STUDY 22
2.4 CURRENCY AND PRICING 22
2.5 DBMR TRIPOD DATA VALIDATION MODEL 23
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 26
2.7 DBMR MARKET POSITION GRID 27
2.8 VENDOR SHARE ANALYSIS 29
2.9 MULTIVARIATE MODELLING 30
2.10 TYPE TIMELINE CURVE 31
2.11 MARKET APPLICATION COVERAGE GRID 32
2.12 SECONDARY SOURCES 33
2.13 ASSUMPTIONS 33
3 EXECUTIVE SUMMARY 34
4 PREMIUM INSIGHTS 36
4.1 PESTEL ANALYSIS 37
4.2 PORTER'S FIVE FORCES ANALYSIS 38
5 REGULATORY FRAMEWORK 39
6 MARKET OVERVIEW 41
6.1 DRIVERS 43
6.1.1 GROWING ACCEPTANCE OF ECOA AMONG CLINICAL RESEARCH PROFESSIONALS 43
6.1.2 PARADIGM SHIFT TOWARDS ELECTRONIC DATA CAPTURING FROM PAPER-BASED PROCEDURES 44
6.1.3 GOVERNMENT INITIATIVES ABOUT THE ADOPTION OF ECLINICAL PLATFORMS 45
6.2 RESTRAINTS 46
6.2.1 IMPLEMENTATION OF 'BRING YOUR OWN DEVICE' (BYOD) TECHNOLOGY IN CLINICAL TRIALS 46
6.2.2 LACK OF PROPER HEALTHCARE IT INFRASTRUCTURE IN DEVELOPING COUNTRIES 47
6.3 OPPORTUNITIES 47
6.3.1 GROWING ADOPTION OF CLOUD-BASED SERVICES 47
6.3.2 RISING NUMBER OF RESEARCH STUDIES FOCUSING ON CLINICAL OUTCOME ASSESSMENTS 48
6.4 CHALLENGES 49
6.4.1 DIFFICULTIES ASSOCIATED WITH TRAINING OF RESPONDENTS TO FILL ELECTRONIC QUESTIONNAIRES 49
6.4.2 STREAMLINING OF ECOA SERVICES 49
7 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE 51
7.1 OVERVIEW 52
7.2 CLINICIAN REPORTED OUTCOME ASSESSMENT (CLINRO) 53
7.3 PATIENT REPORTED OUTCOME ASSESSMENT (PRO) 54
7.4 OBSERVER REPORTED OUTCOME ASSESSMENT (OBSRO) 54
7.5 PERFORMANCE OUTCOME ASSESSMENT (PERFO) 55
8 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY 56
8.1 OVERVIEW 57
8.2 SITE-BASED SOLUTIONS 58
8.3 WEB SOLUTIONS 59
8.4 HANDHELD 59
8.4.1 BRING-YOUR-OWN-DEVICE (BYOD) 60
8.4.2 PROVISIONED DEVICES 60
9 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER 61
9.1 OVERVIEW 62
9.2 CONTRACT RESEARCH ORGANIZATIONS (CROS) 63
9.2.1 SITE-BASED SOLUTIONS 64
9.2.2 WEB SOLUTIONS 64
9.2.3 HANDHELD 64
9.3 PHARMACEUTICAL AND BIOTECHNOLOGY FIRMS 64
9.3.1 SITE-BASED SOLUTIONS 65
9.3.2 WEB SOLUTIONS 65
9.3.3 HANDHELD 65
9.4 MEDICAL DEVICE COMPANIES 65
9.4.1 SITE-BASED SOLUTIONS 66
9.4.2 WEB SOLUTIONS 66
9.4.3 HANDHELD 66
9.5 HOSPITALS/HEALTHCARE PROVIDERS 66
9.5.1 SITE-BASED SOLUTIONS 67
9.5.2 WEB SOLUTIONS 67
9.5.3 HANDHELD 67
9.6 CONSULTING SERVICE COMPANIES 67
9.6.1 SITE-BASED SOLUTIONS 68
9.6.2 WEB SOLUTIONS 68
9.6.3 HANDHELD 68
9.7 ACADEMIC & RESEARCH INSTITUTES 68
9.7.1 SITE-BASED SOLUTIONS 69
9.7.2 WEB SOLUTIONS 69
9.7.3 HANDHELD 69
9.8 OTHERS 69
9.8.1 SITE-BASED SOLUTIONS 70
9.8.2 WEB SOLUTIONS 70
9.8.3 HANDHELD 70
10 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY DELIVERY MODE 71
10.1 OVERVIEW 72
10.2 CLOUD-BASED 73
10.3 WEB-HOSTED 73
11 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION 74
11.1 NORTH AMERICA 76
11.1.1 U.S. 81
11.1.2 CANADA 86
11.1.3 MEXICO 90
12 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: COMPANY LANDSCAPE 95
12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 95
13 SWOT ANALYSIS 96
?
14 COMPANY PROFILE 97
14.1 MEDIDATA 97
14.1.1 COMPANY SNAPSHOT 97
14.1.2 REVENUE ANALYSIS 97
14.1.3 COMPANY SHARE ANALYSIS 98
14.1.4 SOLUTION PORTFOLIO 98
14.1.5 RECENT DEVELOPMENTS 98
14.2 IQVIA INC 101
14.2.1 COMPANY SNAPSHOT 101
14.2.2 REVENUE ANALYSIS 101
14.2.3 COMPANY SHARE ANALYSIS 102
14.2.4 PRODUCT PORTFOLIO 102
14.2.5 RECENT DEVELOPMENTS 102
14.3 CLARIO 104
14.3.1 COMPANY SNAPSHOT 104
14.3.2 COMPANY SHARE ANALYSIS 104
14.3.3 SOLUTION PORTFOLIO 105
14.3.4 RECENT DEVELOPMENTS 105
14.4 SIGNANT HEALTH 107
14.4.1 COMPANY SNAPSHOT 107
14.4.2 SOLUTION PORTFOLIO 107
14.4.3 RECENT DEVELOPMENTS 108
14.5 ARISNORTH AMERICA 109
14.5.1 COMPANY SNAPSHOT 109
14.5.2 SOLUTION PORTFOLIO 109
14.5.3 RECENT DEVELOPMENTS 111
14.6 ASSISTEK 113
14.6.1 COMPANY SNAPSHOT 113
14.6.2 SERVICE PORTFOLIO 113
14.6.3 RECENT DEVELOPMENT 114
14.7 CASTOR 115
14.7.1 COMPANY SNAPSHOT 115
14.7.2 PRODUCT PORTFOLIO 115
14.7.3 RECENT DEVELOPMENTS 116
14.8 CLIMEDO HEALTH GMBH 117
14.8.1 COMPANY SNAPSHOT 117
14.8.2 PRODUCT PORTFOLIO 117
14.8.3 RECENT DEVELOPMENT 117
?
14.9 CLINCAPTURE 118
14.9.1 COMPANY SNAPSHOT 118
14.9.2 PRODUCT PORTFOLIO 118
14.9.3 RECENT DEVELOPMENT 118
14.10 CLINICAL INK 119
14.10.1 COMPANY SNAPSHOT 119
14.10.2 SOLUTION PORTFOLIO 119
14.10.3 RECENT DEVELOPMENTS 120
14.11 CLOUDBYZ 121
14.11.1 COMPANY SNAPSHOT 121
14.11.2 SOLUTION PORTFOLIO 121
14.11.3 RECENT DEVELOPMENTS 121
14.12 CRUCIAL DATA SOLUTIONS 123
14.12.1 COMPANY SNAPSHOT 123
14.12.2 SOLUTION PORTFOLIO 123
14.12.3 RECENT DEVELOPMENTS 123
14.13 EVIDENTIQ 125
14.13.1 COMPANY SNAPSHOT 125
14.13.2 PRODUCT PORTFOLIO 125
14.13.3 RECENT DEVELOPMENTS 126
14.14 KAYENTIS 127
14.14.1 COMPANY SNAPSHOT 127
14.14.2 SOLUTION PORTFOLIO 127
14.14.3 RECENT DEVELOPMENTS 127
14.15 MEDABLE INC. 129
14.15.1 COMPANY SNAPSHOT 129
14.15.2 PRODUCT PORTFOLIO 129
14.15.3 RECENT DEVELOPMENTS 130
14.16 MERATIVE 131
14.16.1 COMPANY SNAPSHOT 131
14.16.2 SOLUTION PORTFOLIO 131
14.16.3 RECENT DEVELOPMENTS 131
14.17 PATTERN HEALTH TECHNOLOGIES, INC. 133
14.17.1 COMPANY SNAPSHOT 133
14.17.2 SERVICE PORTFOLIO 133
14.17.3 RECENT DEVELOPMENTS 133
14.18 RAYLYTIC GMBH 135
14.18.1 COMPANY SNAPSHOT 135
14.18.2 SOLUTION PORTFOLIO 135
14.18.3 RECENT DEVELOPMENT 136
14.19 SUVODA LLC 137
14.19.1 COMPANY SNAPSHOT 137
14.19.2 PRODUCT PORTFOLIO 137
14.19.3 RECENT DEVELOPMENT 138
14.20 TRANSPERFECT LIFE SCIENCES 139
14.20.1 COMPANY SNAPSHOT 139
14.20.2 SOLUTION PORTFOLIO 139
14.20.3 RECENT DEVELOPMENT 140
14.21 VITALOGRAPH 141
14.21.1 COMPANY SNAPSHOT 141
14.21.2 SERVICES PORTFOLIO 141
14.21.3 RECENT DEVELOPMENTS 142
14.22 WCG CLINICAL 143
14.22.1 COMPANY SNAPSHOT 143
14.22.2 PRODUCT PORTFOLIO 143
14.22.3 RECENT DEVELOPMENT 143
14.23 YPRIME LLC. 145
14.23.1 COMPANY SNAPSHOT 145
14.23.2 SOLUTION PORTFOLIO 145
14.23.3 RECENT DEVELOPMENTS 146
15 QUESTIONNAIRE 148
16 RELATED REPORTS 151
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.